DeepMind의 유전체 AI가 희귀 질환 미스터리를 해결하는 데 어떻게 도움을 줄 수 있는가

Ewen Callaway (금요일,)가 이 질문을 연구했습니다.

www.synapsesocial.com/papers/69a75ebec6e9836116a299da — DOI: https://doi.org/10.1038/d41586-026-00302-8

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Undiagnosed Hackathon Ends Diagnostic Odyssey in a Patient With <scp> <i>DNA2</i> </scp> ‐Related Rothmund–Thomson Syndrome· 2025 · 3 citations
2. Proteome-wide model for human disease genetics· 2025 · 14 citations
3. Advancing regulatory variant effect prediction with AlphaGenome· 2026 · 73 citations
4. ClinVar: improving access to variant interpretations and supporting evidence· 2017 · 4,404 citations
5. Variant scoring performance across selection regimes depends on variant-to-gene and gene-to-disease components